I got my PhD in 2013 in the Chemo-informatics field, in the group of Prof. Alexandre Varnek at the University of Strasbourg. I have been working for the last few years, both in academic and private environments, on the docking and optimization of fragment-like compounds within the framework of in silico Fragment-Based Drug Design. I joined the Morelli/Collette team in May 2015 at the Cancer Research Center of Marseille in order to work on both protein-protein interaction inhibitors and molecular modeling approaches to improve affinity of hits from screening campaigns. For instance, I developed the molecular modeling part of the DOTS pipeline, an integrated strategy for lead optimization relying on both computational chemistry and robotic platform.